Neogenomics (NEO) EBT Margin (2010 - 2026)
Neogenomics (NEO) posted EBT Margin of 9.42% for Q1 2026, down 44.34% quarter-over-quarter from 6.52% in Q4 2025, and up 585.0% year-on-year from 1.37% in Q1 2025.
Neogenomics (NEO) EBT Margin (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported EBT Margin for 17 consecutive years, with 9.42% the latest figure, recorded in Q1 2026.
- EBT Margin for Q1 2026 came in at 9.42%, up 585.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.7% (down 200.0% YoY), and the FY2025 annual result was 15.16%, down 295.0% from the prior year.
- EBT Margin was 9.42% for Q1 2026 at Neogenomics, down from 6.52% in the prior quarter.
- Over five years, EBT Margin peaked at 6.52% in Q4 2025 and troughed at 45.37% in Q1 2022.
- Average EBT Margin over 5 years is 18.46%, with a median of 15.27% recorded in 2025.
- Year-over-year, EBT Margin plunged 9314 bps in 2022 and jumped 2080 bps in 2023.
- Over 5 years, EBT Margin stood at 18.4% in 2022, then jumped by 47 bps to 9.83% in 2023, then advanced by 5 bps to 9.38% in 2024, then soared by 30 bps to 6.52% in 2025, then tumbled by 44 bps to 9.42% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 9.42% in Q1 2026, 6.52% in Q4 2025, and 14.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.16% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.17% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 22.23% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 7.90% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 22.14% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.42% |
| Dec 31, 2025 | -6.52% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | -25.27% |
| Mar 31, 2025 | -15.27% |
| Dec 31, 2024 | -9.38% |
| Sep 30, 2024 | -10.64% |
| Jun 30, 2024 | -11.56% |
| Mar 31, 2024 | -17.72% |
| Dec 31, 2023 | -9.83% |
| Sep 30, 2023 | -14.12% |
| Jun 30, 2023 | -18.13% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | -18.40% |
| Sep 30, 2022 | -30.77% |
| Jun 30, 2022 | -32.81% |
| Mar 31, 2022 | -45.37% |
| Dec 31, 2021 | -35.16% |
| Sep 30, 2021 | -19.10% |
| Jun 30, 2021 | 60.33% |